| NDC Code | 37000-532-08 |
|---|
| Package Description | 236 mL in 1 BOTTLE, PLASTIC (37000-532-08) |
|---|
| Product NDC | 37000-532 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Dayquil Severe Plus |
|---|
| Proprietary Name Suffix | Vicks Vapocool |
|---|
| Non-Proprietary Name | Acetaminophen, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide, And Guaifenesin |
|---|
| Dosage Form | SOLUTION |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20180710 |
|---|
| End Marketing Date | 20230322 |
|---|
| Marketing Category Name | OTC MONOGRAPH FINAL |
|---|
| Application Number | M012 |
|---|
| Manufacturer | The Procter & Gamble Manufacturing Company |
|---|
| Substance Name | ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
|---|
| Strength | 650; 20; 400; 10 |
|---|
| Strength Unit | mg/30mL; mg/30mL; mg/30mL; mg/30mL |
|---|
| Pharmacy Classes | Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC] |
|---|